<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[cancer Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/cancer.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to cancer]]></description>
	<s:counts start="0" returned="20" found="38" />
	<language>en-us</language>
	<item>
		<title><![CDATA[The Business Conundrums of Trying to Prevent Cancer]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005391/the-business-conundrums-of-trying-to-prevent-cancer/]]></link>
		<description><![CDATA[An article in last week's New York Times said drug companies are not particularly interested in preventing cancer -- because patients aren't particularly interested in buying drugs for cancer prevention. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Nov 2009 21:21:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[BioPure Exec Sentenced to Three Years for Faking Cancer to Avoid SEC Probe]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005338/biopure-exec-sentenced-to-three-years-for-faking-cancer-to-avoid-sec-probe/]]></link>
		<description><![CDATA[Howard Richman better hope there's no such thing as karma. The former BioPure vice president was sentenced last month to three years in prison for faking cancer to avoid an SEC investigation. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 16 Nov 2009 20:00:03 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005135/has-gentas-energizer-bunny-of-cancer-drugs-finally-run-out-of-juice/]]></link>
		<description><![CDATA[The most surprising thing about last week's Phase III failure of beleaguered cancer drug Genasense was that Genta's stock plummeted. Seriously, who didn't see this one coming? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 21:56:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004901/amgens-denosumab-delay-not-a-deal-breaker-cancer-remains-the-big-question/]]></link>
		<description><![CDATA[The FDA's complete response letter to Amgen regarding approval of denosumab for postmenopausal osteoporosis was an unpleasant surprise that could have been much worse, but the drugâ€™s biggest test is yet to come when the agency reviews its bids in cancer. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 19 Oct 2009 21:21:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[Roche Developing a "Hedgehog Inhibitor" for Cancer]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004839/roche-developing-a-hedgehog-inhibitor-for-cancer/]]></link>
		<description><![CDATA[Roche has a "hedgehog inhibitor" in Phase 2 of development, according to an investor presentation that accompanied its Q3 2009 results. Don't panic. This is not a substance intended to kill the spiny-but-adorable endangered species native to the hedgerows of Europe. Rather, it's a new therapy for basal cell carcinoma...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 15 Oct 2009 13:07:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Latest Gardasil-for-Boys Scare Tactic: Penile Cancer]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003947/latest-gardasil-for-boys-scare-tactic-penile-cancer/]]></link>
		<description><![CDATA[Back in November, BNET suggested we were about to see a media campaign full of scary stuff -- anal cancer, anyone? -- for which the prevention is Merck's HPV vaccine, Gardasil. This week, it arrived. Spanish researchers found that 46.9 percent of all penile cancers are caused by HPV. by...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 27 Aug 2009 13:25:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Cancer drug audit set for late start]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F43518fb8-8874-11de-82e4-00144feabdc0.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Eight months after promising to audit the demand for cancer and other drugs that the NHS declines to fund, pilot projects to achieve that have yet to be launched, the Department of Health said yesterday.The pilot schemes should finally begin "later this year", a spokesman said as the Rarer...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 13 Aug 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/audit.html"><![CDATA[Audit]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/government+news.html"><![CDATA[Government News]]></category>
		<category domain="http://resources.bnet.com/topic/government+spending.html"><![CDATA[Government Spending]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[Cynicism Winning Debate Over Sanofi's Lantus and Cancer]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002989/cynicism-winning-debate-over-sanofis-lantus-and-cancer-2/]]></link>
		<description><![CDATA[In the flap over whether Sanofi-Aventis' Lantus diabetes drug has an association with cancer, cynicism seems to be winning. Sanofi's stock see graph seems not to have recovered from reports that Lantus was linked to cancer, even though Sanofi obtained an approval for a new heart drug, Multaq. Meanwhile, Sanofi's...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 07 Jul 2009 07:41:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[UPDATED: Sanofi's Lantus Cancer Scare Triggered by Doc Backed by Amylin and Lilly]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002930/sanofis-lantus-cancer-scare-triggered-by-doc-backed-by-amylin-and-lilly/]]></link>
		<description><![CDATA[The editors of medical journal backed off from a study they published suggesting Sanofi-Aventis' diabetes drug Lantus was linked to cancer. At the same time, it emerged that the doctor who warned of an "earthquake" on Lantus has done work endorsed or sponsored by Amylin and Eli Lilly, marketers of...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 01 Jul 2009 09:22:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diabetes.html"><![CDATA[Diabetes]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Sanofi's Lantus Cancer Scare Shows How Enormous Power Lies With Few Experts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002909/sanofis-lantus-cancer-scare-shows-how-enormous-power-lies-with-few-experts/]]></link>
		<description><![CDATA[The cancer scare over Sanofi-Aventis' Lantus shows just how much power over a company's drug sales -- and its stock -- are now concentrated in the hands of a tiny number of experts. Sanofi CEO Chris Viehbacher came out of his corner swinging Monday, saying an article in Study of...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 29 Jun 2009 13:47:04 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi.html"><![CDATA[Sanofi]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Health Insurers Canceling Policies Without Warning]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/economic-news/video/health-insurers-canceling-policies-without-warning/300723/]]></link>
		<description><![CDATA[Some patients with serious illnesses have discovered their insurance companies are dropping them and charging them for treatment after the fact. Sandra Hughes reports on this alarming trend.]]></description>
		<s:doctype><![CDATA[Videos]]></s:doctype>
		<pubDate>Sun, 10 May 2009 18:49:54 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/insurance+company.html"><![CDATA[Insurance Company]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/moneywatch.html"><![CDATA[MoneyWatch]]></category>
		<category domain="http://resources.bnet.com/topic/insurance.html"><![CDATA[Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+insurance.html"><![CDATA[Corporate Insurance]]></category>
		<category domain="http://resources.bnet.com/topic/evening.html"><![CDATA[Evening]]></category>
		<category domain="http://resources.bnet.com/topic/hughes.html"><![CDATA[Hughes]]></category>
		<category domain="http://resources.bnet.com/topic/health.html"><![CDATA[Health]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/hmo.html"><![CDATA[HMO]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/treatment.html"><![CDATA[Treatment]]></category>
		<category domain="http://resources.bnet.com/topic/surgery.html"><![CDATA[Surgery]]></category>
		<category domain="http://resources.bnet.com/topic/hospital.html"><![CDATA[Hospital]]></category>
		<category domain="http://resources.bnet.com/topic/operation.html"><![CDATA[Operation]]></category>
		<category domain="http://resources.bnet.com/topic/chemo.html"><![CDATA[Chemo]]></category>
		<category domain="http://resources.bnet.com/topic/america.html"><![CDATA[America]]></category>
		<category domain="http://resources.bnet.com/topic/socialized.html"><![CDATA[Socialized]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin Insists Byetta Doesn't Cause Cancer; Wall Street Doesn't Seem So Sure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001760/amylin-insists-byetta-doesnt-cause-cancer-wall-street-doesnt-seem-so-sure/]]></link>
		<description><![CDATA[Amylin CEO Daniel Bradbury may be wishing that Novo Nordisk's failed competitor to its diabetes drug Byetta had actually been approved by the FDA. Had Novo's liraglutide passed muster, no one would have gotten the jitters over whether Byetta gives you cancer or not.    At Amylin's conference...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 21 Apr 2009 13:27:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[Byetta]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Myriad Genetics Inc. F2Q09 (Qtr End 12/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-265817.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Our first question comes from the line of Charles Duncan of JMP Securities. Please proceed with your question. Charles Duncan - JMP Securities  Hi, guys. Good morning and congratulations on a very good quarter. My question is regarding perhaps the breadth of potential...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Tue, 03 Feb 2009 11:15:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/myriad+genetics+inc..html"><![CDATA[Myriad Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MYGN</category>
		<category domain="tickers">MYGN</category>
	</item>
	<item>
		<title><![CDATA[Dissecting Merck's "Gardasil for Boys" FDA Application]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000557/dissecting-mercks-gardasil-for-boys-fda-application/]]></link>
		<description><![CDATA[Merck has filed an application with the FDA for the use of the HPV vaccine Gardasil in boys. The move was predicted by BNET on Nov. 14. It will likely spur two debates, one over the safety of the vaccine and another over whether Gardasil is actually cost-effective enough to...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 06:21:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/hpv.html"><![CDATA[HPV]]></category>
		<category domain="http://resources.bnet.com/topic/star+gazette.html"><![CDATA[Star Gazette]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[ArQule Joins Forces with Daiichi Sankyo to Fight Cancer]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F105369-arqule-joins-forces-with-daiichi-sankyo-to-fight-cancer%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Eben Tessari submits:  ArQule and Daiichi Sankyo announced that they have entered into two agreements that form the basis of a strategic relationship for the development and discovery of novel oncology therapeutics. One agreement covers the license of ARQ 197 and the other is an R&D agreement.  ARQ...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Tue, 11 Nov 2008 08:13:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[Agreement]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/arq+197.html"><![CDATA[ARQ 197]]></category>
		<category domain="http://resources.bnet.com/topic/eben+tessari.html"><![CDATA[Eben Tessari]]></category>
		<category domain="http://resources.bnet.com/topic/arqule+inc..html"><![CDATA[ArQule Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARQL</category>
		<category domain="tickers">ARQL</category>
	</item>
	<item>
		<title><![CDATA[Gen-Probe Wages Bidding War For Diagnostics Crown]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100087/gen-probe-wages-bidding-war-for-diagnostics-crown/]]></link>
		<description><![CDATA[Diagnostic tests traditionally haven't gotten a huge amount of respect within the drug industry. Until recently, at least, most diagnostics were low-margin, almost commodity products that couldn't command the high prices -- much less the repeat business -- that drugs themselves could.    That's started to change with...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 04 Jun 2008 13:26:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/salary.html"><![CDATA[Salary]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[Diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/gen-probe.html"><![CDATA[Gen-Probe]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[NeoGenomics Inc: The Wall Street Analyst Forum Presentation Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-231619.html]]></link>
		<description><![CDATA[ Earnings Call Excerpt NeoGenomics Inc. NGNM Wall Street Analyst Forum Presentation November 28, 2007 10:30 am ET Executives Robert Gasparini &#8211; President & Chief Science Officer Steven Jones - Chief Financial Officer Presentation Moderator Good morning ladies and gentlemen. I&#8217;d like to go ahead and introduce the next company...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 28 Nov 2007 11:48:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/laboratory.html"><![CDATA[Laboratory]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/neogenomics+inc..html"><![CDATA[NeoGenomics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cancer+genetic.html"><![CDATA[Cancer Genetic]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
	</item>
	<item>
		<title><![CDATA[The Impact of Age on Post-Operative Outcomes of Colorectal Cancer Patients Undergoing Surgical Treatment]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=158047]]></link>
		<description><![CDATA[The purpose of study was to evaluate the impact of age on outcomes in colorectal cancer surgery. Patients on hospital database treated for colorectal cancer during the period 1995 - 2002 were divided into two groups: Group 1 - patients of 75 years or older (n = 154), and Group...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 02 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/biomed+central.html"><![CDATA[BioMed Central]]></category>
		<category domain="http://resources.bnet.com/topic/surgery.html"><![CDATA[Surgery]]></category>
		<category domain="http://resources.bnet.com/topic/complication.html"><![CDATA[Complication]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
	</item>
	<item>
		<title><![CDATA[Increased Risk of Cancer Among Relatives of Patients With Lung Cancer in China]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=158049]]></link>
		<description><![CDATA[Genetic factors were considered as one of the risk factors for lung cancer or other cancers. The aim of this paper was to determine whether a genetic predisposition accounts for such familial aggregation of cancer among relatives of lung cancer probands. A case-control study was conducted in 800 case families...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Fri, 11 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/lung+cancer.html"><![CDATA[Lung Cancer]]></category>
	</item>
	<item>
		<title><![CDATA[Technical Advances in Colorectal Cancer Screening]]></title>
		<link><![CDATA[http://jobfunctions.bnet.com/abstract.aspx?docid=255425]]></link>
		<description><![CDATA[In the colon and rectum, the vast majority of cancers develop very slowly, approximately over a period of 10 to 15 years, from benign precursor lesions. These lesions, so-called polyps, can undergo malignant transformations based on the adenoma-carcinoma sequence. Therefore, the resection of polyps reduces colorectal cancer mortality by over...]]></description>
		<s:doctype><![CDATA[White papers]]></s:doctype>
		<pubDate>Sat, 01 Oct 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/siemens+ag.html"><![CDATA[Siemens AG]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SI</category>
		<category domain="tickers">SI</category>
	</item>
</channel>
</rss>
